Literature DB >> 27541606

Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".

Karin Wirdefeldt1,2, Per Odin3,4, Dag Nyholm5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27541606     DOI： 10.1007/s40263-016-0379-7

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  6 in total

1.  Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.

Authors:  Angelo Antonini; Ashley Yegin; Cornelia Preda; Lars Bergmann; Werner Poewe
Journal:  Parkinsonism Relat Disord       Date:  2014-12-19       Impact factor: 4.891

Review 2.  Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".

Authors:  Andrew T Lambarth
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

Review 3.  Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.

Authors:  Karin Wirdefeldt; Per Odin; Dag Nyholm
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

4.  Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

Authors:  C Warren Olanow; Karl Kieburtz; Per Odin; Alberto J Espay; David G Standaert; Hubert H Fernandez; Arvydas Vanagunas; Ahmed A Othman; Katherine L Widnell; Weining Z Robieson; Yili Pritchett; Krai Chatamra; Janet Benesh; Robert A Lenz; Angelo Antonini
Journal:  Lancet Neurol       Date:  2013-12-20       Impact factor: 44.182

5.  Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.

Authors:  David Devos
Journal:  Mov Disord       Date:  2009-05-15       Impact factor: 10.338

Review 6.  Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Authors:  Dag Nyholm
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 5.577
  6 in total
  1 in total

1.  Initial Experience of the Levodopa-Entacapone-Carbidopa Intestinal Gel in Clinical Practice.

Authors:  Mezin Öthman; Erik Widman; Ingela Nygren; Dag Nyholm
Journal:  J Pers Med       Date:  2021-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.